Literature DB >> 32265293

Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS.

Samvel K Gularyan1, Alexander A Gulin2, Ksenia S Anufrieva3, Victoria O Shender4, Michail I Shakhparonov5, Soniya Bastola6, Nadezhda V Antipova5, Tatiana F Kovalenko5, Yury P Rubtsov5, Yaroslav A Latyshev7, Alexander A Potapov7, Marat S Pavlyukov8.   

Abstract

Glioblastoma (GBM) is one of the most aggressive human cancers with a median survival of less than two years. A distinguishing pathological feature of GBM is a high degree of inter- and intratumoral heterogeneity. Intertumoral heterogeneity of GBM has been extensively investigated on genomic, methylomic, transcriptomic, proteomic and metabolomics levels, however only a few studies describe intratumoral heterogeneity because of the lack of methods allowing to analyze GBM samples with high spatial resolution. Here, we applied TOF-SIMS (Time-of-flight secondary ion mass spectrometry) for the analysis of single cells and clinical samples such as paraffin and frozen tumor sections obtained from 57 patients. We developed a technique that allows us to simultaneously detect the distribution of proteins and metabolites in glioma tissue with 800 nm spatial resolution. Our results demonstrate that according to TOF-SIMS data glioma samples can be subdivided into clinically relevant groups and distinguished from the normal brain tissue. In addition, TOF-SIMS was able to elucidate differences between morphologically distinct regions of GBM within the same tumor. By staining GBM sections with gold-conjugated antibodies against Caveolin-1 we could visualize border between zones of necrotic and cellular tumor and subdivide glioma samples into groups characterized by different survival of the patients. Finally, we demonstrated that GBM contains cells that are characterized by high levels of Caveolin-1 protein and cholesterol. This population may partly represent a glioma stem cells. Collectively, our results show that the technique described here allows to analyze glioma tissues with a spatial resolution beyond reach of most of other omics approaches and the obtained data may be used to predict clinical behavior of the tumor.
© 2020 Gularyan et al.

Entities:  

Keywords:  Glioblastoma; TOF-SIMS; cancer biomarker(s); caveolin-1; glioma; imaging visualization tools; mass spectrometry; stem cells

Year:  2020        PMID: 32265293      PMCID: PMC7261812          DOI: 10.1074/mcp.RA120.001986

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  57 in total

Review 1.  Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.

Authors:  M A Qazi; P Vora; C Venugopal; S S Sidhu; J Moffat; C Swanton; S K Singh
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

2.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

Review 3.  Active membrane cholesterol as a physiological effector.

Authors:  Yvonne Lange; Theodore L Steck
Journal:  Chem Phys Lipids       Date:  2016-02-10       Impact factor: 3.329

Review 4.  Molecular and cellular heterogeneity: the hallmark of glioblastoma.

Authors:  Diane J Aum; David H Kim; Thomas L Beaumont; Eric C Leuthardt; Gavin P Dunn; Albert H Kim
Journal:  Neurosurg Focus       Date:  2014-12       Impact factor: 4.047

5.  Graphene quantum dots enhanced ToF-SIMS for single-cell imaging.

Authors:  Hao-Wen Li; Xin Hua; Yi-Tao Long
Journal:  Anal Bioanal Chem       Date:  2019-02-22       Impact factor: 4.142

6.  Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Authors:  Sriram Venneti; Mark P Dunphy; Hanwen Zhang; Kenneth L Pitter; Patrick Zanzonico; Carl Campos; Sean D Carlin; Gaspare La Rocca; Serge Lyashchenko; Karl Ploessl; Daniel Rohle; Antonio M Omuro; Justin R Cross; Cameron W Brennan; Wolfgang A Weber; Eric C Holland; Ingo K Mellinghoff; Hank F Kung; Jason S Lewis; Craig B Thompson
Journal:  Sci Transl Med       Date:  2015-02-11       Impact factor: 17.956

7.  Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.

Authors:  Sidse Ehmsen; Martin H Pedersen; Guisong Wang; Mikkel G Terp; Amina Arslanagic; Brian L Hood; Thomas P Conrads; Rikke Leth-Larsen; Henrik J Ditzel
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

8.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

9.  In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging.

Authors:  Delphine Debois; Marie-Pierre Bralet; François Le Naour; Alain Brunelle; Olivier Laprévote
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

10.  Prognostic factors for long-term survival after glioblastoma.

Authors:  Mohammad Sami Walid
Journal:  Perm J       Date:  2008
View more
  12 in total

1.  A Reliable Approach for Revealing Molecular Targets in Secondary Ion Mass Spectrometry.

Authors:  Fengxia Li; Eugenio F Fornasiero; Tal M Dankovich; Verena Kluever; Silvio O Rizzoli
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

2.  Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging.

Authors:  Anya B Zhong; Isabella H Muti; Stephen J Eyles; Richard W Vachet; Kristen N Sikora; Cedric E Bobst; David Calligaris; Sylwia A Stopka; Jeffery N Agar; Chin-Lee Wu; Mari A Mino-Kenudson; Nathalie Y R Agar; David C Christiani; Igor A Kaltashov; Leo L Cheng
Journal:  Front Mol Biosci       Date:  2022-04-08

3.  microRNA-27a-3p delivered by extracellular vesicles from glioblastoma cells induces M2 macrophage polarization via the EZH1/KDM3A/CTGF axis.

Authors:  Guifang Zhao; Hongquan Yu; Lijuan Ding; Weiyao Wang; Huan Wang; Yao Hu; Lingsha Qin; Guangce Deng; Buqing Xie; Guofeng Li; Ling Qi
Journal:  Cell Death Discov       Date:  2022-05-14

4.  Coated Blade Spray-Mass Spectrometry as a New Approach for the Rapid Characterization of Brain Tumors.

Authors:  Joanna Bogusiewicz; Magdalena Gaca-Tabaszewska; Dominik Olszówka; Karol Jaroch; Jacek Furtak; Marek Harat; Janusz Pawliszyn; Barbara Bojko
Journal:  Molecules       Date:  2022-03-30       Impact factor: 4.411

Review 5.  Multimodal Imaging Mass Spectrometry: Next Generation Molecular Mapping in Biology and Medicine.

Authors:  Elizabeth K Neumann; Katerina V Djambazova; Richard M Caprioli; Jeffrey M Spraggins
Journal:  J Am Soc Mass Spectrom       Date:  2020-09-04       Impact factor: 3.262

6.  Multiphoton Microscopy and Mass Spectrometry for Revealing Metabolic Heterogeneity of Hepatocytes in vivo.

Authors:  S A Rodimova; D S Kuznetsova; N V Bobrov; A A Gulin; A A Vasin; M V Gubina; V I Scheslavsky; V V Elagin; M M Karabut; V E Zagainov; E V Zagaynova
Journal:  Sovrem Tekhnologii Med       Date:  2021-04-30

7.  Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes.

Authors:  Joanna Bogusiewicz; Bogumiła Kupcewicz; Paulina Zofia Goryńska; Karol Jaroch; Krzysztof Goryński; Marcin Birski; Jacek Furtak; Dariusz Paczkowski; Marek Harat; Barbara Bojko
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 8.  Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine.

Authors:  Yechen Hu; Zhongcheng Wang; Liang Liu; Jianhua Zhu; Dongxue Zhang; Mengying Xu; Yuanyuan Zhang; Feifei Xu; Yun Chen
Journal:  Chem Sci       Date:  2021-05-25       Impact factor: 9.825

Review 9.  Current Immunotherapeutic Approaches for Malignant Gliomas.

Authors:  Myung-Hoon Han; Choong Hyun Kim
Journal:  Brain Tumor Res Treat       Date:  2022-01

10.  Detection of Label-Free Drugs within Brain Tissue Using Orbitrap Secondary Ion Mass Spectrometry as a Complement to Neuro-Oncological Drug Delivery.

Authors:  Phoebe McCrorie; Jonathan Rowlinson; David J Scurr; Maria Marlow; Ruman Rahman
Journal:  Pharmaceutics       Date:  2022-03-05       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.